Expertise in
5
conditions

Alan L. Whone

Bristol, ENG, GB 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
Bristol, ENG, GB 
OverviewLocationsClinical Research

Overview

Alan Whone practices in Bristol, United Kingdom. Mr. Whone is highly rated in 5 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Movement Disorders, Myoclonus-Dystonia, Deep Brain Stimulation, and Gastrostomy.

His clinical research consists of co-authoring 59 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Bristol, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Enrollment Status: Recruiting
Publish Date: May 28, 2024
Intervention Type: Device
CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease: A Phase 3 Randomised, Double-blind Placebo-controlled Trial of Rivastigmine to Prevent Falls in Parkinson's Disease.
CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease: A Phase 3 Randomised, Double-blind Placebo-controlled Trial of Rivastigmine to Prevent Falls in Parkinson's Disease.
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Other, Drug
Study Drug: Rivastigmine Transdermal System
Study Phase: Phase 3
A Randomized, Placebo-controlled, Phase IIa Study Evaluating the Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia
A Randomized, Placebo-controlled, Phase IIa Study Evaluating the Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia
Enrollment Status: Completed
Publish Date: March 31, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trial

59 Total Publications

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy.
Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy.
Journal: Annals of neurology
Published: March 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Whone's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile